Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Genprex Inc
(NQ:
GNPX
)
2.330
-0.150 (-6.05%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Genprex Inc
< Previous
1
2
3
4
Next >
Genprex to Present in November CEO Roadshow Webinar
November 16, 2021
From
Genprex, Inc.
Via
Business Wire
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Strengthens Management Team with Strategic Appointments
September 28, 2021
Via
Investor Brand Network
Genprex Strengthens Management Team with Appointments of Industry Leaders Mark S. Berger, M.D. as Chief Medical Officer and Hemant Kumar, Ph.D. as Chief Manufacturing and Technology Officer
September 28, 2021
From
Genprex, Inc.
Via
Business Wire
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation in Two Upcoming Investor Conferences
September 20, 2021
Via
Investor Brand Network
Genprex to Participate in September Investor Conferences
September 20, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex to Participate in a Monthly CEO Roadshow Webinar Series
July 20, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer Following FDA Review
June 23, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex Announces Participation in Noble Capital Markets’ Virtual Roadshow Series
May 19, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex to Participate in Upcoming May Investor Conferences
May 10, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex In-Licenses Additional Gene Therapy Technologies for Treatment of Lung Cancer
May 06, 2021
From
Genprex, Inc.
Via
Business Wire
Diamond Equity Research Emerging Growth Invitational Spring 2021 Virtual Conference
May 06, 2021
- One Day Conference May 11, 2021 - 25 Minute Presenting Time Slots From 8:30am to 1:25pm EST - Presentation Times and Links Distributed for All Presenting Companies - Investors Will Be Provided Time...
From
Diamond Equity Research LLC
Via
AccessWire
Genprex Announces Centralized Institutional Review Board Approval for Acclaim-1 Clinical Trial in Non-Small Cell Lung Cancer
May 05, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex Initiates Site Recruitment for Acclaim-2 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
May 04, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex to Participate in CEO Roadshow Webinar Series
April 21, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex to Receive Inaugural “License of the Year” Award from University of Pittsburgh Innovation Institute in Recognition of Advances Made with Gene Therapy Program in Diabetes
April 20, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the 2021 AACR Annual Meeting
April 12, 2021
From
Genprex, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.